OTCMKTS:SBMFF - Sino Biopharm Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$2.51 +0.15 (+6.36 %)
(As of 05/28/2018 06:00 AM ET)
Previous Close$2.51
Today's Range$2.49 - $2.52
52-Week Range$0.84 - $2.52
Volume37,760 shs
Average Volume15,432 shs
Market Capitalization$21.15 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Sino Biopharm (OTCMKTS:SBMFF)

Sino Biopharm logoSino Biopharmaceutical Limited, researches, develops, manufactures, and markets Chinese medicines and chemical medicines in Hong Kong. The company operates through three segments: Modernized Chinese Medicines and Chemical Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Tianqingganmei injections, Runzhong dispersible tablets, Mingzheng capsules, Tianqingganping enteric capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Yilunping and Tuotuo tablets, as well as Tianqingning injections; and oncology medicines consisting of Zhiruo, Saiweijian, and Tianqingyitai injections. The company's principal products also include Orthopedic medicines, which comprise New Ossified Triol capsules and Jiuli tablets; anti-infectious medicines, including Tiance injections; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and anorectal medicines comprising Getai tablets. In addition, it develops medicines for treating tumors, analgesia, diabetes, and other diseases; engages in the retail of pharmaceutical products; provides medical management consultancy services; and manufactures, sells, and distributes health food products, as well as is involved in optometry for optical glasses and sale of ophthalmic products. Further, the company provides research and development services; and operates Chia Tai Shaoyang Orthopedic Hospital. Sino Biopharmaceutical Limited was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.

Receive SBMFF News and Ratings via Email

Sign-up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:SBMFF
CUSIPN/A
Phone852-2802-9886

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.04 billion
Price / Sales10.37
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees18,163
Outstanding Shares8,425,190,000

Sino Biopharm (OTCMKTS:SBMFF) Frequently Asked Questions

What is Sino Biopharm's stock symbol?

Sino Biopharm trades on the OTCMKTS under the ticker symbol "SBMFF."

Who are some of Sino Biopharm's key competitors?

Who are Sino Biopharm's key executives?

Sino Biopharm's management team includes the folowing people:
  • Ms. Y. Y. Tse, Chairlady (Age 25)
  • Mr. Ping Tse, Founder, CEO, Pres, Compliance Officer & Exec. Director (Age 66)
  • Mr. Zhoushan Tian, Exec. Director (Age 54)
  • Mr. Shanchun Wang, Exec. Director (Age 50)
  • Ms. Mingqin Li, VP & Exec. Director (Age 59)

Has Sino Biopharm been receiving favorable news coverage?

Media stories about SBMFF stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Sino Biopharm earned a daily sentiment score of 0.18 on Accern's scale. They also assigned media headlines about the company an impact score of 46.85 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of Sino Biopharm?

Shares of SBMFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sino Biopharm's stock price today?

One share of SBMFF stock can currently be purchased for approximately $2.51.

How big of a company is Sino Biopharm?

Sino Biopharm has a market capitalization of $21.15 billion and generates $2.04 billion in revenue each year. Sino Biopharm employs 18,163 workers across the globe.

How can I contact Sino Biopharm?

Sino Biopharm's mailing address is Rm 4109 Office Tower Convention Plaza 1 Harbour Road Wanchai, Hong Kong K3, . The company can be reached via phone at 852-2802-9886 or via email at [email protected]


MarketBeat Community Rating for Sino Biopharm (SBMFF)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  21 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  52
MarketBeat's community ratings are surveys of what our community members think about Sino Biopharm and other stocks. Vote "Outperform" if you believe SBMFF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBMFF will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Sino Biopharm (OTCMKTS:SBMFF) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/ASellSell
Consensus Rating Score: N/AN/A1.001.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Sino Biopharm (OTCMKTS:SBMFF) Consensus Price Target History

Price Target History for Sino Biopharm (OTCMKTS:SBMFF)

Sino Biopharm (OTCMKTS:SBMFF) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
4/18/2017Jefferies GroupInitiated CoverageUnderperformView Rating Details
(Data available from 5/28/2016 forward)

Earnings

Sino Biopharm (OTCMKTS:SBMFF) Earnings History and Estimates Chart

Earnings by Quarter for Sino Biopharm (OTCMKTS:SBMFF)

Sino Biopharm (OTCMKTS SBMFF) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/26/2017Q1 2017$0.01$560.75 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Sino Biopharm (OTCMKTS:SBMFF) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Sino Biopharm (OTCMKTS SBMFF) Insider Trading and Institutional Ownership History

Insider Trading History for Sino Biopharm (OTCMKTS:SBMFF)

Sino Biopharm (OTCMKTS SBMFF) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Sino Biopharm (OTCMKTS SBMFF) News Headlines

Source:
DateHeadline
BRIEF-Sino Biopharmaceutical Posts Qtrly Net Profit Of RMB771.1 MlnBRIEF-Sino Biopharmaceutical Posts Qtrly Net Profit Of RMB771.1 Mln
finance.yahoo.com - May 18 at 11:39 AM
BRIEF-Sino Biopharmaceutical Says Unit Obtained Approval For Drug Registration By China FDABRIEF-Sino Biopharmaceutical Says Unit Obtained Approval For Drug Registration By China FDA
finance.yahoo.com - May 10 at 10:45 AM
Sino Biopharmaceutical Limited (HKG:1177): What Can We Expect From This High Growth Stock?Sino Biopharmaceutical Limited (HKG:1177): What Can We Expect From This High Growth Stock?
finance.yahoo.com - May 3 at 10:14 AM
BRIEF-Sino Biopharmaceutical Says Compound Sodium Acetate Ringers Injection Gets Drug Registration ApprovalsBRIEF-Sino Biopharmaceutical Says Compound Sodium Acetate Ringer's Injection Gets Drug Registration Approvals
finance.yahoo.com - May 2 at 10:14 AM
Sino Biopharmaceutical Limited’s (HKG:1177) Insiders Ramped Up Holdings – Should You?Sino Biopharmaceutical Limited’s (HKG:1177) Insiders Ramped Up Holdings – Should You?
finance.yahoo.com - April 25 at 10:43 AM
Sino Biopharmaceut (SBMFF) Upgraded by Zacks Investment Research to "Buy"Sino Biopharmaceut (SBMFF) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - April 11 at 3:24 PM
Sino Biopharmaceut (SBMFF) Cut to Hold at Zacks Investment ResearchSino Biopharmaceut (SBMFF) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - April 8 at 10:46 PM
Sino Biopharmaceut (SBMFF) Downgraded by Zacks Investment ResearchSino Biopharmaceut (SBMFF) Downgraded by Zacks Investment Research
www.americanbankingnews.com - March 29 at 1:29 PM
Sino Biopharmaceut (SBMFF) Lowered to Hold at Zacks Investment ResearchSino Biopharmaceut (SBMFF) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - March 26 at 7:08 PM
At $14.38, Is It Time To Buy Sino Biopharmaceutical Limited (HKG:1177)?At $14.38, Is It Time To Buy Sino Biopharmaceutical Limited (HKG:1177)?
finance.yahoo.com - March 8 at 11:11 AM
How Sino Biopharmaceutical Limited (HKG:1177) Delivered A Better ROE Than Its IndustryHow Sino Biopharmaceutical Limited (HKG:1177) Delivered A Better ROE Than Its Industry
finance.yahoo.com - February 22 at 10:16 AM
Should You Be Tempted To Sell Sino Biopharmaceutical Limited (HKG:1177) At Its Current PE Ratio?Should You Be Tempted To Sell Sino Biopharmaceutical Limited (HKG:1177) At Its Current PE Ratio?
finance.yahoo.com - February 9 at 8:29 AM
Is Sino Biopharmaceutical Limited (HKG:1177) Expensive For A Reason? A Look At The Intrinsic ValueIs Sino Biopharmaceutical Limited (HKG:1177) Expensive For A Reason? A Look At The Intrinsic Value
finance.yahoo.com - January 31 at 8:30 AM
Sino Biopharmaceut (SBMFF) Raised to Buy at Zacks Investment ResearchSino Biopharmaceut (SBMFF) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - January 19 at 12:30 PM
Sino Biopharmaceut (SBMFF) Lifted to Buy at Zacks Investment ResearchSino Biopharmaceut (SBMFF) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - January 5 at 6:38 AM
Zacks Investment Research Downgrades Sino Biopharmaceut (SBMFF) to HoldZacks Investment Research Downgrades Sino Biopharmaceut (SBMFF) to Hold
www.americanbankingnews.com - January 4 at 6:40 PM
ETFs with exposure to Sino Biopharmaceutical Ltd. : December 29, 2017ETFs with exposure to Sino Biopharmaceutical Ltd. : December 29, 2017
finance.yahoo.com - December 29 at 5:48 PM
Research Analysts Offer Predictions for Sino Biopharmaceuts FY2017 Earnings (SBMFF)Research Analysts Offer Predictions for Sino Biopharmaceut's FY2017 Earnings (SBMFF)
www.americanbankingnews.com - December 13 at 8:08 AM
Sino Biopharmaceutical Ltd. : Fairly valued, but may deserve another lookSino Biopharmaceutical Ltd. : Fairly valued, but may deserve another look
finance.yahoo.com - December 1 at 4:14 PM

SEC Filings

Sino Biopharm (OTCMKTS:SBMFF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Sino Biopharm (OTCMKTS SBMFF) Stock Chart for Monday, May, 28, 2018

Loading chart…

This page was last updated on 5/28/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.